Efficacy and safety of scopolamine compared to placebo in individuals with bipolar disorder who are experiencing a depressive episode (SCOPE-BD): study protocol for a randomised double-blind placebo-controlled trial

BACKGROUND: Current treatment options for the management of depressive episodes in bipolar disorder are often sub-optimal, with some treatments either noted to be only partially effective or to require long durations of treatment prior to a therapeutic response. Therefore, pharmaco-therapeutic optio...

Descripción completa

Detalles Bibliográficos
Autores principales: Miravalles, Cerena, Kane, Ruán, McMahon, Eimear, McDonald, Colm, Cannon, Dara M., Hallahan, Brian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9034496/
https://www.ncbi.nlm.nih.gov/pubmed/35461262
http://dx.doi.org/10.1186/s13063-022-06270-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9034496/
https://www.ncbi.nlm.nih.gov/pubmed/35461262
http://dx.doi.org/10.1186/s13063-022-06270-4

Ejemplares similares